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ABSTRACT 29 
 30 
PURPOSE: The primary outcome of this study is to compare axial length growth of white 31 
European myopic children wearing orthokeratology contact lenses (OK) to a control group (CT) 32 
over a 7-year period.  33 
 34 
METHODS: Subjects 6-12 years of age with myopia -0.75 to -4.00DS and astigmatism ≤1.00DC 35 
were prospectively allocated OK or distance single-vision spectacles (SV) correction. 36 
Measurements of axial length (Zeiss IOLMaster), corneal topography and cycloplegic refraction 37 
were taken at 6-month intervals over a 2-year period. Subjects were invited to return to the clinic 38 
approximately 5 years later (i.e. 7 years after the beginning of the study) for assessment of their 39 
ocular refractive and biometric components. The CT consisted of 4 SV and 12 subjects who 40 
switched from SV to soft contact lens wear after the initial 2-years of SV lens wear. Changes in 41 
axial length relative to baseline over a 7-year period were compared between groups.  42 
 43 
RESULTS: Fourteen and 16 subjects from the OK and CT groups, respectively were examined 44 
6.7±0.5 years after the beginning of the study. Statistically significant changes in axial length 45 
were found over time and between groups (both p<0.001), but not for the time*group interaction 46 
(p=0.125). The change in axial length for the OK group was 22% (p=0.328), 42% (p=0.007), 47 
40% (p=0.020), 41% (p=0.013) and 33% (p=0.062) lower than the CT group following 6, 12, 18, 48 
24 and 84 months of lens wear, respectively.  49 
 50 
CONCLUSION: A trend towards a reduction in the rate of axial elongation of the order of 33% 51 
was found in the OK group in comparison to the CT group following 7-years of lens wear.  52 
 53 
 54 
 55 
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efficacy 57 
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INTRODUCTION 65 
Globally, uncorrected refractive errors represent the second major cause of 66 
vision loss1 of which myopia is the most common and distinctive in that its 67 
prevalence has increased substantially in recent decades. To date, it has been 68 
estimated that myopia currently affects approximately 30% of the world’s 69 
population,2, 3 although a significant increase to affect around 50% of the 70 
world’s population by 2050 has been forecast.2 The prevalence of myopia in 71 
young adolescents is also increasing and has approached around 25% and up 72 
to 98% in industrialized societies of the West and East Asia, respectively.3 Of 73 
particular concern is that relatively low degrees of myopia may be associated 74 
with increased risk of ocular complications, such as vitreous and chorioretinal 75 
detachment, macular degeneration, and glaucoma all of which can increase the 76 
risk of vision loss.4–7  Furthermore, myopia incurs substantial expenditure such 77 
that in the USA, the annual cost for eye examinations and corrections by 78 
spectacles and contact lenses has been estimated to be between $2 and $5 79 
billion.8, 9 Therefore, finding effective therapies to slow the progression of 80 
myopia could potentially benefit millions of individuals and save on substantial 81 
healthcare expenditure worldwide.  82 
 83 
Several optical treatment options have been used in the past with limited 84 
success to eliminate or, at least, reduce myopia progression in children.10-12 Of 85 
these, orthokeratology (OK) contact lens wear appears to be one of the most 86 
effective as it has consistently been shown to reduce the axial elongation of the 87 
eye by 30 to 50% in comparison with conventional single-vision spectacle (SV) 88 
and soft contact lens (SCL).13-18 Most previous studies have demonstrated 89 
reduced rates in axial elongation over 2 years of OK lens wear. A recent meta-90 
analysis study reported that the pooled reduction in axial elongation declined 91 
with time, with 55, 51, 51, and 41% obtained after 6, 12, 18, and 24 months of 92 
OK lens wear, respectively.19 However, little is known about the efficacy of OK 93 
lens wear in reducing the rate of axial elongation for longer periods of lens 94 
wear. Two retrospective studies have shed some light on the latter.20, 21 Kwok-95 
Hei Mok and Sin-Ting Chung compared changes in myopia over a 7-year period 96 
between 34 children with a mean age at baseline of 9 years wearing OK and 36 97 
children with a mean age at baseline of 10 years wearing SV.20 Determination 98 
 4 
of the final refractive error of the OK lens wearing subjects was conducted by 99 
the washout period method, whereby subjects were refracted after not wearing 100 
the lenses for a period of time until the flatter corneal meridian reverted to its 101 
pre-OK levels.20 It took a mean (± standard deviation) of 25.5±1.0 (range 22–102 
29) days for the central flat corneal curvature to return to pre-OK levels. 103 
Average myopic progression for the OK group (−0.37±0.49D) was significantly 104 
lower than that found for the SV group (−2.06±0.81D) following 7-years of lens 105 
wear.20 Downie and Lowe compared the progression rate of manifest refractive 106 
prescription in myopic children under the age of 16 years between 26 OK lens 107 
wearers and 30 age- and refraction-matched SV wearers in 2 yearly intervals 108 
over a period up to 8 years.21 The study found that OK wearers showed a 109 
significantly more stable myopic refractive prescription than SV over all of the 2-110 
year treatment intervals, indicating that OK can reduce the rate of progression 111 
of childhood myopia over the long term.21 Furthermore, a subpopulation of OK 112 
lens wearers (64%) demonstrated an apparent total arrest of manifest myopic 113 
refractive change.21 Although the above two studies have provided preliminary 114 
evidence for the long-term efficacy of OK contact lens wear in reducing the 115 
progression of myopia their limitations are retrospective study designs, non-116 
randomization of subjects to study groups and the use of non-cycloplegic 117 
refractions as primary outcome measures. Furthermore, neither of the studies 118 
measured axial length, the key structural correlate of myopic progression in OK-119 
treated eyes.22 Hiraoka et al. compared changes in axial length between 22 OK 120 
and 21 SV Japanese lens wearers with a mean age at baseline of 10 years 121 
over a period of 5 years.23 The study found statistically significant reductions in 122 
the annual increases in axial length in the OK group compared with the SV 123 
group for the first, second, and third years, but not for the fourth and fifth 124 
years.23  125 
 126 
We have previously reported the results of the Myopia Control with 127 
Orthokeratology contact lens in Spain (MCOS) study which evaluated 128 
differences in growth of axial length over a 2-year period in white European 129 
children with myopia wearing OK and SV.17 We found a statistically significant 130 
difference in axial length elongation relative to baseline between the OK 131 
(0.47±0.18mm) and SV (0.69±0.32mm) groups (p=0.005).17 Approximately 5 132 
 5 
years after completion of the MCOS study, subjects were contacted by 133 
telephone and invited to return to the clinic for evaluation of their ocular 134 
refractive and biometric parameters. The purpose of this study is to compare, as 135 
the primary outcome measure, differences in growth of axial length over a 7-136 
year period between white European myopic children wearing OK and a control 137 
group (CT) wearing SV or SCL. Additionally, refractive and biometric changes in 138 
subjects who switched corrections were also evaluated.  139 
 140 
 141 
 142 
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METHODS 144 
This study was part of a larger study designed to assess different aspects of OK 145 
lens wear specifically prescribed for the control of myopia progression in 146 
children.17, 24-27 The methods employed in MCOS have been described in detail 147 
elsewhere.17, 24 In brief, normal, healthy white European subjects 6 to 12 years 148 
of age with moderate levels of mean spherical myopia (-0.75 to -4.00D) and 149 
astigmatism (≤1.00D) and free of systemic or ocular disease were fitted with 150 
Menicon Z Night contact lenses for overnight use (Menicon Co., Ltd, Nagoya, 151 
Japan). An OK fit was considered to be successful if the subject showed a 152 
CCLRU score regarding anterior eye segment signs ≤ 1 unit, a “bull’s eye” 153 
corneal topography pattern and monocular and binocular visual acuities within 154 
±1 line of the best-correct spectacle visual acuity. All subjects underwent ocular 155 
examinations including slit-lamp examination, manifest refraction, and corneal 156 
topography at baseline and at 6-month intervals over a 2-year period. Follow-up 157 
visits were scheduled to fall within 2 hours of awakening in order to measure 158 
subjective refraction and visual acuity without the lens on the eye. A decrease 159 
in one line of visual acuity accompanied by a change in subjective refraction at 160 
any of the follow-up visits was considered clinically significant and was 161 
remedied by supplying new contact lenses. Approximately 5 years after 162 
completion of the MCOS study, subjects were contacted by telephone and 163 
invited to return to the clinic for evaluation of their ocular refractive and 164 
biometric parameters. The study was conducted in accordance with the Tenets 165 
of the Declaration of Helsinki and approved by the Institutional Ethical 166 
Committee Review Board of Novovision Ophthalmology Clinic (Madrid, Spain). 167 
Full informed consent and child assent was obtained in writing from the 168 
parents/guardians prior to the start of all experimental work and data collection. 169 
Patient participation in the study could be discontinued at the examiner’s 170 
discretion should significant symptoms or slit-lamp findings occur. Subjects 171 
were instructed they could withdraw from the study at any time. 172 
 173 
Cycloplegic auto-refraction was performed following the instillation of three 174 
drops of cyclopentolate HCl 1% separated 10 min apart in each of the subjects’ 175 
eyes using a multidose bottle (Alcon Cusí, Masnou, Barcelona, Spain). Ten 176 
minutes after the instillation of the third drop, three auto-refraction 177 
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measurements were taken and a mean obtained (Topcon RM 8000B, CA, 178 
USA).  179 
 180 
Measurements of axial length were taken with the Zeiss IOLMaster (Carl Zeiss 181 
Jena GmbH).28 Three separate measurements of axial length were recorded 182 
and a mean obtained.  183 
 184 
Corneal topography measurements were performed with the Wavelight Allegro 185 
Topolyzer (WaveLight Laser Technologies AG, Erlangen, Germany). The 186 
instrument incorporates a high resolution placido-ring corneal topographer 187 
which detects 22,000 elevated data points of measurement from 22 ring edges 188 
with a claimed accuracy and reproducibility of ± 0.10D according to the 189 
manufacturer. The first measurement taken for each eye, which provided an 190 
optimum index value according to the manufacturer’s recommendations, was 191 
used for the study. The measurement generates a simulated central 192 
keratometry reading and the rate of peripheral corneal flattening/steepening that 193 
occurs with displacement from the corneal apex; the latter indicates the degree 194 
to which an aspheric surface differs from the spherical form (i.e., the p value). 195 
The p value was calculated over a 7-mm chord in accord with the default setting 196 
of the instrument. 197 
 198 
Statistical analysis 199 
Differences in subjects’ demographics and baseline data between groups were 200 
tested using unpaired sample t-tests for all variables, except for the male:female 201 
ratio which was tested using a chi-square test. Changes (from baseline) in 202 
refractive and biometric data over time and between groups (i.e. OK vs. CT) 203 
were tested using a general linear model (GLM) with repeated measures to test 204 
the statistical significance of differences in outcome variables (i.e. axial length, 205 
spherical and cylindrical refractive components, corneal power and corneal 206 
shape) for the between-subject factor of refractive correction (two levels: OK 207 
and CT) and for the within-subject factor of time (five levels: 6, 12, 18, 24 and 208 
84 months). The significance of the interaction between OK and CT with respect 209 
to time was then tested for all time intervals combined and then separately for 210 
each of the five time intervals following post hoc Bonferroni correction. GLM 211 
 8 
with repeated measures was also used to test the effect of switching treatments 212 
from OK to SCL. Additionally, an unpaired sample t-test was used to test, for 213 
each time point, differences between the groups in refractive and biometric 214 
variables. Equality of variances and sphericity were tested using the Levene 215 
and Mauchly tests respectively to select appropriate p-values. Additionally, 216 
simple linear regressions between the change in axial length at 7-years relative 217 
to baseline and baseline age, mean spherical equivalent refractive error, axial 218 
length, mean central corneal power and corneal shape factor were calculated 219 
for the OK and CT groups separately. Differences between groups in the slopes 220 
of the regression lines were compared using an analysis of covariance. The 221 
strength of association between the different factors is summarized using linear 222 
regression equations, R2 squared values and p-values. Data are expressed as 223 
mean ± 1 standard error of the mean (SEM). Data from right eyes only were 224 
used for analysis. Statistical analyses were performed with IBM SPSS Statistics 225 
(IBM Corp., Ver. 22, NY, USA) and graphing with SigmaPlot (Systat software 226 
Inc, California, USA). The level of statistical significance was set at 5%.   227 
 228 
 229 
 230 
 231 
 232 
 233 
 234 
 235 
 236 
 237 
 238 
 239 
 240 
 241 
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RESULTS 243 
At the inception of MCOS sixty-nine subjects were examined for eligibility: 8 244 
subjects were not eligible to participate and 31 and 30 children were 245 
prospectively allocated to OK and SV, respectively (Figure 1). Twenty-nine and 246 
24 subjects from the OK and SV groups, respectively, thus completed the initial 247 
2 years of the MCOS study. Seven subjects were subsequently lost to follow- 248 
up in each group and no further information was able to be collected from these 249 
subjects leading to a total of 39 subjects of the original cohort available for 250 
review at the 7-year visit. Of these, 14 and 4 remained in their original OK and 251 
SV lens wear categories, respectively. In addition, twelve of the 39 subjects 252 
switched to standard SCL wear after 2 years of SV lens wear which thus 253 
constituted a control group (CT) of 16 subjects (i.e. 4 SV + 12 SCL). Nine 254 
subjects switched lens wear category and the effect of which was assessed 255 
separately (see subheading below) (Figure 1). 256 
 257 
Long-terms effects in the OK and CT groups 258 
The OK and CT groups were followed for 6.9±0.1 and 6.5±0.1 years, 259 
respectively; this difference was statistically significant (p=0.001). Subjects 260 
reported inserting and removing their OK lenses every night and morning, 261 
respectively. None of the subjects from the OK group reported cessation of lens 262 
wear for any significant periods of time over the entire 7-year period of OK lens 263 
wear. Furthermore, all subjects reported ≥ 0.9 uncorrected decimal visual 264 
acuities (equivalent to 0.05 logMAR or >20/25) at the 7-year visit. The 265 
incidence, type and timeline of adverse events found over the initial 24 months 266 
of the study have been previously reported.25 At the 84-month visit, all subjects 267 
underwent a thorough ophthalmic examination and no remarkable adverse 268 
events were found. Furthermore, none of the subjects reported any significant 269 
complications in the last 5 years of lens wear. The 12 subjects who switched to 270 
standard SCL wear after 2 years of SV lens wear and who became part of the 271 
CT group worn SCL for 2.5±0.4 years prior to the 7-years visit. No statistically 272 
significant differences between the OK and CT groups were found in any of the 273 
baseline demographics and refractive and biometric data (Table 1).  274 
 275 
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Statistically significant changes were found in axial length both over time and 276 
between groups (p<0.001), but not for the time*group interaction (p=0.125) 277 
(Figure 2 and Table 2).  Changes over time were statistically significant for all 278 
pairs of time points (all p≤0.001) (Figure 2 and Table 2). In comparison to the 279 
CT group, the change in axial length for the OK group was 22% (p=0.328), 42% 280 
(p=0.007), 40% (p=0.020), 41% (p=0.013) and 33% (p=0.062) lower following 6, 281 
12, 18, 24 and 84 months of lens wear, respectively (Figure 2 and Table 2).  282 
 283 
Statistically significant differences were also found in the spherical component 284 
of the refraction over time, between groups and for the time*group interaction 285 
(all p<0.001) (Table 2). Statistically significant differences between time points 286 
were found between 6- and 12-, 18-, 24- and 84-months (all p<0.01); between 287 
12- and 84-months (p=0.002); between 18- and 24- and 84-months (both 288 
p<0.001); and between 24- and 84-months (p<0.001) (Table 2). Statistically 289 
significant differences were found between groups at all the different time points 290 
(p<0.001) (Table 2). However, no statistically significant differences were found 291 
in the cylindrical component of the refraction over time, between groups or for 292 
the time*group interaction (p>0.05) (Table 2).  293 
 294 
Statistically significant differences were found in corneal power over time (both 295 
p<0.001) and between groups (both p<0.001), but not for the time*group 296 
interaction (both p>0.05) for both the flatter and steeper meridians (Table 2). 297 
Significant differences were found for pairs of time points between 6-, 12-, 18-, 298 
24- and 84-months for both meridians (all p≤0.02 ) (Table 2). Significant 299 
differences were also found between groups in corneal power at all time points 300 
for both meridians (all p<0.001) (Table 2). However, no significant differences 301 
were found in the corneal shape (i.e. corneal p-value) over time, between 302 
groups or for the time*group interaction (all p>0.05) (Table 2).  303 
 304 
Univariate linear regression analysis revealed that the older the age at baseline 305 
the smaller the axial elongation at 7-years in both study groups, although the 306 
relationship was statistically significant for the CT (R2=0.274, p=0.022), but not 307 
for the OK group (R2=0.142, p=0.101). The effect of baseline age on axial 308 
elongation was, however, similar between groups (p=0.208) (Figure 3 and 309 
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Table 3). Greater corneal powers at baseline were associated with smaller 310 
increases in axial length in the OK group (R2=0.290, p=0.027), but no significant 311 
relationship was found for the CT group (R2=0.000, p=0.817) (Figure 4 and 312 
Table 3). Furthermore, statistically significant differences were found between 313 
groups in the slopes of the regression lines (p=0.044) (Figure 4 and Table 3). 314 
No significant relationships were found between the change in axial length at 7-315 
years in comparison to baseline and baseline mean spherical equivalent 316 
refractive error, axial length and corneal shape for either the OK or CT groups 317 
(Table 3). In addition, no statistically significant differences were found between 318 
groups in the slopes of the regression lines for either spherical equivalent 319 
refractive error, axial length or corneal shape (all p>0.05) (Table 3).  320 
 321 
The effect of switching treatments 322 
Following 2 years of OK lens wear, eight subjects (4 male and 4 female) 323 
switched from OK to SCL 1.7±0.5 years (range 0.2 to 3.9 years) thereafter and 324 
wore SCL for the last 3.3±0.5 years (range 1.3 to 5.3 years). A trend was found 325 
for increased time of SCL wear to be associated with shorter increases in axial 326 
length (Figure 5). The reasons for switching from OK to SCL were (number of 327 
subjects): expensive treatment (4), recurrent punctate keratitis (2) and concerns 328 
regarding regression (1) and efficacy (1). These subjects had mean ages of 329 
9.3±0.4, 11.4±0.4 and 16.4±0.5 at baseline, following 2 years of OK lens wear 330 
and at the 7-years study visit, respectively. On average, axial length increased 331 
by 0.57±0.06mm during the initial 2 years of OK lens wear and by 0.80±0.16mm 332 
on the subsequent 5 years (Table 4), although there was large between-subject 333 
variability (Figure 6). As expected, the increase in axial length following 334 
cessation of OK lens wear was associated with an increase in myopia, a 335 
steepening of corneal curvature and a more prolate corneal shape (Table 3). In 336 
comparison to the CT group (Table 2), these subjects experienced mean 337 
reductions in the rate of axial elongation of 47%, 30%, 22% and 19% following 338 
6, 12, 18 and 24 months of OK lens wear, respectively (Tables 2 and 4). 339 
However, when these subjects switched from OK to SCL the rate of axial 340 
elongation observed at 84 months in comparison to the CT group was -1%, 341 
indicating the effect of OK lens wear in reducing the rate of axial elongation is 342 
negligible with discontinuation of lens wear (Tables 2 and 4). One male subject 343 
 12 
switched from SV to OK lens wear immediately after the initial 2 years of SV 344 
lens wear and wore OK lenses for the following 5 years. The reason for 345 
changing to OK was to reduce the rate of myopia progression. In this subject, 346 
axial length increased by 0.81mm during the initial 2 years of SV lens wear, but 347 
only by 0.35mm in the following 5 years of OK lens wear (Table 4).  348 
 349 
  350 
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DISCUSSION 351 
This study assessed the long-term efficacy of OK lens wear in reducing the rate 352 
of axial elongation over a period of as long as 7 years in White European 353 
subjects. The significant reduction in manifest myopia and the rate of myopia 354 
progression found in the OK group after initial lens wear remained throughout 355 
the 7-year period and is primarily attributed to the corneal reshaping effect 356 
induced by OK contact lens wear and the resultant change in corneal power 357 
and shape (Table 2). The CT group, however, showed an average increase in 358 
myopia of 2.84D accompanied by negligible changes in corneal power and 359 
shape (Table 2).  360 
 361 
Of interest is the finding of a trend towards a reduction in the rate of axial 362 
elongation of the order of 33% in the OK group in comparison to the CT group 363 
following 7-years of lens wear (Figure 2 and Table 2). Interestingly, a study 364 
estimated that reducing the rate of myopia progression by 33% would lead to a 365 
reduction of 73% in the frequency of high myopia (<-5.00D);29 such reduction 366 
could therefore have important implications in terms of reducing ocular-related 367 
morbidity7 and healthcare costs.8, 9  368 
 369 
Despite differences in corneal topography and contact lens-induced responses 370 
between Caucasian and Japanese ethnicities have been previously reported,30, 371 
31 our results are similar to those reported by Hiraoka et al.23 We found OK to 372 
reduce the rate of axial elongation by 33% after 7 years of lens wear, whereas 373 
Hiraoka et al. found OK to reduce the rate of axial elongation by 31% after 5 374 
years of lens wear.23 The study of Hiraoka et al. was performed in Japanese 375 
subjects using one particular OK contact lens design (i.e. αOrtho-K; Alpha 376 
Corp., Nagoya, Japan),23 whereas the present study was undertaken in White 377 
European subjects using a different OK lens design (i.e. Menicon Z Night, 378 
Menicon Co., Ltd, Nagoya, Japan). Interestingly, our results also agree with 379 
those of Hiraoka et al. in that the benefit of OK in reducing the axial elongation 380 
of eye diminishes with longer periods of lens wear.  381 
 382 
The reduced efficacy of myopia control with long periods of lens wear found in 383 
this study may be attributed to the natural history of myopia progression, in 384 
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which there is a reduced rate of axial elongation with increased age, thereby 385 
making it more difficult to find significant differences between groups in axial 386 
length over longer periods of lens wear (Figures 2 and 3, and Table 2). In fact, 387 
the increases in axial length over the first 24 months of this study were 388 
remarkably similar to those found between 24 and 84 months for both the OK 389 
(0.42±0.05 and 0.39±0.04mm, respectively) and the CT (0.71±0.10 and 390 
0.65±0.11mm, respectively) groups, clearly indicating a decrease in the rate of 391 
axial elongation regardless of the visual correction being worn (Figure 3 and 392 
Table 2). It is well established that older age is associated with smaller 393 
increases in myopia and axial elongation. Furthermore, it has been previously 394 
reported that myopia stabilizes at around 16 years of age.32 Subjects in this 395 
study had mean ages of 10 and 12 years at baseline and following 2 years of 396 
OK lens wear, respectively. Therefore, a reduced rate of myopia progression 397 
would be expected on these subjects during the subsequent 5 years of data 398 
collection.  399 
 400 
Greater corneal power was found to be associated with smaller axial elongation 401 
in OK wearers (Figure 4). Following OK lens wear, a steeper cornea is likely to 402 
provide a smaller treatment zone of central corneal flattening33 and a wider 403 
peripheral ring of increased corneal power. Therefore, it is feasible that a 404 
steeper cornea facilitates corneal reshaping and reduction in axial elongation 405 
following OK lens wear.12, 26 406 
 407 
The large variability in the increases in axial length found in the 8 subjects who 408 
discontinued OK lens wear at 2-years and switched to SCL wear could be 409 
attributed to the length of time that SCLs were worn after ceasing OK lens wear 410 
(Figure 5), individual differences and differences in the power profile between 411 
the different SCLs worn (Figure 6).34 In any event, the results found on the 412 
effect of switching treatments appear to be consistent with those found in the 413 
OK and CT groups over the 7-year period in that the efficacy of OK diminishes 414 
and resumes with discontinuation and restoration of OK lens wear, respectively.  415 
 416 
A limitation of this study is the potential bias introduced by subjects’ self-417 
selection to continue wearing OK, SV or SCL. However, the major limitation 418 
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concerns the relatively small sample size employed in this study. The overall 419 
power to detect between-subjects differences (i.e. OK vs. CT) in the general 420 
linear model employed in our study was P=0.68 (IBM SPSS Statistics). 421 
However, the power varied at each of the different time points, being lowest at 422 
the 6- (P=0.16) and 84-month visits (P=47) and highest at the 12- (P=0.81), 18- 423 
(P=0.76) and 24-month visits (P=0.73), indicating that the relatively low 424 
statistical power found at the 84-month visit is not only related to the sample 425 
size employed but also to the large variability in changes in axial length in both 426 
the OK (0.91 ± 0.63 mm) and CT (1.36 ± 0.63 mm) groups. Taking the standard 427 
deviation of the change in axial length (0.63) and the difference in axial length 428 
found between groups at the 84-month visit (0.45 mm), a sample size of 32 429 
subjects per group would be needed for a designated statistical power of 0.80 430 
at alpha = 0.05. Despite the above-mentioned limitations, our study offers 431 
notable features such as being the first study to assess the efficacy of OK lens 432 
wear in White European subjects in reducing the rate of axial elongation over a 433 
period of as long as 7 years. In addition, the study measures changes in axial 434 
elongation over the entire follow-up period with the IOLMaster, a partial 435 
coherence interferometer well known to provide excellent resolution and 436 
repeatability.28 Nonetheless, randomized, controlled, clinical trials are warranted 437 
to confirm the findings of this study. 438 
 439 
In summary, a trend towards a reduction in the rate of axial elongation of the 440 
order of 33% was found with long-term OK lens wear in comparison to SV and 441 
SCL wearers over a period of 7 years. The reduction observed over time in the 442 
efficacy of OK lens wear in slowing the axial elongation of the eye might be 443 
partly attributed to axial length (and myopia) stabilization as children approach 444 
the teenage years.32 Reducing myopia progression has important implications 445 
in terms of reducing ocular-related morbidity7 and healthcare costs.8, 9  446 
 447 
 448 
 449 
 450 
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FIGURE LEGENDS 631 
 632 
Figure 1. Flow-chart of the subjects recruited for the study. SV, distance single-633 
vision spectacles, SCL, soft contact lenses.  634 
 635 
Figure 2. Changes (mean ± SD) in axial length (mm) from baseline over time 636 
for the OK (black, solid circles) and CT (white, open circles) groups. Error bars 637 
represent one standard error of the mean. Asterisks indicate statistically 638 
significant differences in the change in axial length between groups at 12-, 18- 639 
and 24-months time intervals (all p≤0.02). OK, orthokeratology; CT, control 640 
 641 
Figure 3. Simple linear regressions between the change in axial length at 7 642 
years relative to baseline and age at baseline for the orthokeratology (black, 643 
solid circles and solid line) and control groups (white, open circles and dashed 644 
line). 645 
 646 
Figure 4. Simple linear regressions between the change in axial length at 7 647 
years relative to baseline and mean central corneal power at baseline for the 648 
orthokeratology (black, solid circles and solid line) and control groups (white, 649 
open circles and dashed line). 650 
 651 
Figure 5. Simple linear regressions between the change in axial length at 84- 652 
compared with 24-months and the duration of soft contact lens wear. 653 
 654 
Figure 6. Changes in axial length (mm) from baseline over time for eight 655 
subjects who switched from OK to SCL after an initial phase of 2 years of OK 656 
lens wear. OK, orthokeratology; SCL, soft contact lens. 657 
 658 
 659 
 660 
 661 
 662 
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TABLE LEGENDS 665 
 666 
Table 1. Baseline demographics, refractive and biometric data for both 667 
treatment groups. Variables are expressed as mean ± 1SEM. OK, 668 
orthokeratology; CT, control. 669 
 670 
Table 2. Mean (± SEM) refractive and biometric values for the OK and CT 671 
groups who completed the 7-years study at each time interval. OK, 672 
orthokeratology; CT, control. 673 
 674 
Table 3. Simple linear regressions between the change in axial length at 7-675 
years relative to baseline and the different baseline variables for both the OK 676 
and CT groups. The strength of association between the different factors is 677 
summarized using linear regression equations, R2 values and p-values. OK, 678 
orthokeratology; CT, control; MSE, mean spherical equivalent. 679 
 680 
Table 4. Mean (± SEM) refractive and biometric values for the 8 subjects who 681 
switched from OK to SCL as well as for one single subject who switched from 682 
SV to OK at each time interval. OK, orthokeratology; SCL, soft contact lens; SV, 683 
single-vision spectacles. 684 
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Table 1. Baseline demographics, refractive and biometric data for both treatment groups. Variables are expressed as mean ± SEM 
 
 
 
 
 
 
 
 
 
 
 
 Orthokeratology Control p-value 
Age (years) 10.4 ± 0.5 9.6 ± 0.4 0.244 
Male/female ratio 8/6 7/9 1.00 
Sphere (D) -2.27 ± 0.31 -2.16 ± 0.26 0.375 
Cylinder (mm) -0.25 ± 0.09 -0.30 ± 0.09 0.876 
Axial length (mm) 24.39 ± 0.23 24.08 ± 0.27 0.621 
Flatter meridian (D) 43.18 ± 0.45 43.45 ± 0.46 0.665 
Steeper meridian (D) 43.82 ± 0.41 44.11 ± 0.54 0.667 
Corneal shape factor (p-value) 0.70 ± 0.03 0.70 ± 0.02 0.982 
 Baseline 6-months 12-months 18-months 24-months 84-months 
Refractive components  
Sphere (D)       
Orthokeratology -2.27 ± 0.31 -0.14 ± 0.07 -0.21 ± 0.07 -0.14 ± 0.07 -0.23 ± 0.06 -0.29 ± 0.10 
Control -2.16 ± 0.26 -2.39 ± 0.29 -2.74 ± 0.30 -3.07 ± 0.30 -3.37 ± 0.32 -5.00 ± 0.43 
Cylinder (D)       
Orthokeratology -0.25 ± 0.09 -0.38 ± 0.09 -0.27 ± 0.10 -0.30 ± 0.10 -0.29 ± 0.13 -0.30 ± 0.10 
Control -0.30 ± 0.09 -0.25 ± 0.08 -0.30 ± 0.08 -0.30 ± 0.11 -0.37 ± 0.10 -0.59 ± 0.10 
Biometric components  
Axial length (mm)       
Orthokeratology 24.39 ± 0.23 24.52 ± 0.23 24.41 ± 0.23 24.71 ± 0.24 24.81 ± 0.25 25.30 ± 0.31 
Control 24.08 ± 0.27 24.25 ± 0.27 24.46 ± 0.27 24.61 ± 0.26 24.78 ± 0.26 25.43 ± 0.27 
Flatter corneal meridian power (D)       
Orthokeratology 43.18 ± 0.45 41.32 ± 0.46 41.36 ± 0.48 41.10 ± 0.44 41.36 ± 0.49 40.49 ± 0.41 
Control 43.45 ± 0.46 43.51 ± 0.46 43.52 ± 0.46 43.45 ± 0.45 43.47 ± 0.48 42.69 ± 0.42 
Steeper corneal meridian power (D)       
Orthokeratology 43.82 ± 0.41 42.23 ± 0.47 42.12 ± 0.48 41.99 ± 0.43 42.16 ± 0.47 41.35 ± 0.41 
Control 44.11 ± 0.54 44.29 ± 0.51 43.36 ± 0.51 44.31 ± 0.52 44.18 ± 0.53 43.68 ± 0.45 
Corneal shape factor (p-value)       
Orthokeratology 0.70 ± 0.03 0.82 ± 0.05 0.79 ± 0.04 0.82 ± 0.04 0.76 ± 0.05 0.78 ± 0.05 
Control 0.70 ± 0.02 0.70 ± 0.02 0.73 ± 0.02 0.71 ± 0.02 0.74 ± 0.02 0.69 ± 0.03 
 
Table 2. Mean (± SEM) refractive and biometric values for the OK and CT groups who completed the 7-years study at each time 
interval.  
 
 
 
 Orthokeratology Control Statistical differences between groups in 
the slopes of the regression lines (p-value) 
Age (years) y=-0.165x + 2.620 
R2=0.142, p=0.101 
y=-0.220x + 3.469 
R2=0.274, p=0.022 
p=0.208 
MSE refractive error (D) y=0.070x + 1.073 
R2=0.000, p=0.669 
y=-0.075x + 1.528 
R2=0.000, p=0.653 
p=0.987 
Axial length (mm) y=0.115x - 1.904 
R2=0.000, p=0.591 
y=-0.206x + 6.315 
R2=0.048, p=0.207 
p=0.085 
Mean central keratometry (D) y=-0.235x + 11.131 
R2=0.290, p=0.027 
y=-0.021x + 2.282 
R2=0.000, p=0.817 
p=0.044 
Corneal shape factor (p-value) y=-1.541x + 1.982 
R2=0.000, p=0.376 
y=-1.868x + 2.659 
R2=0.005, p=0.319 
p=0.058 
 
Table 3. Simple linear regressions between the change in axial length at 7-years relative to baseline and the different baseline 
variables for both the OK and CT groups. The strength of association between the different factors is summarized using linear 
regression equations, R2 values and p-values. OK, orthokeratology; CT, control; MSE, mean spherical equivalent 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Baseline 6-months 12-months 18-months 24-months 84-months 
Refractive components 
Sphere (D)       
OK to SCL -2.31 ± 0.38 -0.31 ± 0.06 -0.25 ± 0.13 -0.33 ± 0.08 -0.50 ± 0.12 -4.81 ± 0.62 
SV to OK -3.75  -4.00 -4.00 -4.50 -5.00 -0.25 
Cylinder (D)       
OK to SCL -0.38 ± 0.08 -0.22 ± 0.07 -0.44 ± 0.11 -0.31 ± 0.09 -0.19 ± 0.09 -0.59 ± 0.16 
SV to OK -0.75 -0.75 -0.75 -0.75 -0.50 -0.75 
Biometric components 
Axial length (mm)       
OK to SCL 24.66 ± 0.30 24.75 ± 0.30 24.90 ± 0.32 25.06 ± 0.32 25.23 ± 0.32 26.03 ± 0.41 
SV to OK 25.00  25.39 25.39 25.72 25.81 26.16 
Flatter corneal meridian power (D)       
OK to SCL 42.51 ± 0.75 40.74 ± 0.67 40.84 ± 0.62 40.71 ± 0.74 40.82 ± 0.82 41.54 ± 0.74 
SV to OK 43.30 43.20 43.20 43.44 43.44 40.40 
Steeper corneal meridian power (D)       
OK to SCL 43.24 ± 0.63 41.68 ± 0.70 41.69 ± 0.61 41.78 ± 0.77 41.76 ± 0.79 42.57 ± 0.67 
SV to OK 44.00 43.90 43.90 43.95 44.12 41.5 
Corneal shape factor (p-value)       
OK to SCL 0.65 ± 0.04 0.87 ± 0.05 0.94 ± 0.02 0.85 ± 0.05 0.91 ± 0.04 0.68 ± 0.03 
SV to OK 0.80 0.82 0.85 0.86 0.85 0.94 
 
Table 4. Mean (± SEM) refractive and biometric values for the 8 subjects who switched from OK to SCL as well as for one single 
subject who switched from SV to OK at each time interval. OK, orthokeratology; SCL, soft contact lens; SV, single-vision spectacles 






